Sponsor Pipeline

MAXVAX Biotechnology Limited Liability Company Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
1
Recruiting
4
Phase 3
Active Trials by Phase
Phase 3
4
Phase 2
2
Phase 1/2
1
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07272434 Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO… Respiratory Syncytial Virus (RSV) Recruiting
NCT06447779 Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in… Herpes Zoster Active, Not Recruiting
NCT06654700 Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine… Herpes Zoster Not Yet Recruiting
NCT07293065 A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant… Herpes Zoster Active, Not Recruiting
Phase 2
NCT05621655 Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in… Rotavirus Infections Active, Not Recruiting
NCT05856084 Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy… Herpes Zoster Active, Not Recruiting
Phase 1/2
NCT06642558 Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged… Respiratory Syncytial Virus (RSV) Active, Not Recruiting
Phase 1
NCT05636436 Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy… Herpes Zoster Active, Not Recruiting
NCT07492706 Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV)… Respiratory Syncytial Virus (RSV) Not Yet Recruiting
Not specified
NCT07618325 A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant… Respiratory Syncytial Virus (RSV) Not Yet Recruiting
Get alerts when MAXVAX Biotechnology Limited Liability Company's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free